They further showed CD44 expressing subpopulation of cells in serial xenograft experiments with fresh patient samples and the tumorigenicity of CD44+ bladder cancer cells was found to be 10-200 times higher than CD44- bladder cancer cells when transplanted in immunodeficient mice [5]. The gene discussed is CD44; the disease is urinary bladder carcinoma.